ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Merus NV

Merus NV (2GH)

41.40
-2.00
(-4.61%)
Closed 06 December 8:00AM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
41.40
Bid
41.00
Offer
42.00
Volume
542
43.20 Day's Range 43.80
21.40 52 Week Range 58.50
Previous Close
43.40
Open
43.80
Last Trade
47
@
43.2
Last Trade Time
Average Volume (3m)
114
Financial Volume
-
VWAP
-

2GH Latest News

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen aus...

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-4.1666666666743.247437546.60089286DE
4-8.6-17.25051.540.49946.46118598DE
12-4-8.8105726872245.451.540.411447.6509915DE
26-5.2-11.158798283346.657.540.415348.80237835DE
5220.00000193.457952965321.39999958.521.39999917044.3573342DE
15617.673.949579831923.858.51916541.98058262DE
26017.673.949579831923.858.51916541.98058262DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
17DArcadia Biosciences Inc
5.15 €
(99.61%)
10.94k
1KPAProtara Therapeutics Inc
5.90 €
(75.60%)
16.79k
1ZY0Medaro Mining Corp
0.17 €
(63.46%)
54.1k
TE9Teco 2030 ASA
0.0398 €
(61.79%)
1.04M
L7C2Windfall Geotek Inc
0.006 €
(50.00%)
18k
NL8Genesis Ai Corp
0.0056 €
(-58.82%)
10k
0PV2Moovly Media Inc
0.0025 €
(-58.33%)
859
CNWCodon AG
0.0065 €
(-40.91%)
1.5k
BLEBluebird bio Inc
0.4205 €
(-40.13%)
233.06k
DW8Tantalex Lithium Resources Corp
0.0115 €
(-39.47%)
2k
D7GNel ASA
0.2679 €
(0.15%)
5.5M
AXIAtos SE
0.20 €
(-36.51%)
4.95M
PLUNPlug Power Inc
2.2955 €
(13.55%)
3.17M
R9BDeFi Technologies Inc
3.06 €
(-6.13%)
2.98M
TUI1Tui AG
8.318 €
(5.26%)
2.21M

Discussion

View Full Feed
abazaba375 abazaba375 52 seconds ago
Don't have DM but I agree seatbelts fastened 
SFIO
I-Glow I-Glow 1 minute ago
There are 28 Billion Outstanding Shares - the inertia from that stunning number is too much to move the price - the insiders are manipulating the price with wash trades and spoofing as they always did.

If you want a great account of the HUMBL disaster - read the following.
SRNW
waterchaser waterchaser 1 minute ago
Is it possible that anyone on the “inside” is illiterate?
HIRU
hweb2 hweb2 3 minutes ago
I should have said individual stock boards. And no, not really. I prob follow a hundred of them...and there's hardly ever a post. So mostly useful as alerts for news/filings.
retireat40 retireat40 3 minutes ago
Good move. This thing is a POS. 
PPBT
MartinLutherKing MartinLutherKing 4 minutes ago
It’s the company’s last hurrah, it’s now or never, new website incoming… News incoming.. FDA approval incoming.. partnership incoming….
RNAZ
crazy horse 0 crazy horse 0 4 minutes ago
Monica Crowley IMO is a good one


Trump Picks Popular Fox News Contributor for Key Post

https://truthpress.com/news/trump-picks-popular-fox-news-contributor-for-key-post/?utm_source=truthpress.beehiiv.com&utm_medium=newsletter&utm_campaign=unitedhealthcare-ceo-s
ka ching ka ching 5 minutes ago
Their stock sucks because they don't let anyone donate as They bruised both of my arms then after a week it healed then said I had a red spot on my left arm so I couldn't give in my right arm until the mosquito bite on my lef arm went away They're incompetence is disgusting in Colorado springs Color
GRFS
gitreal gitreal 5 minutes ago
I'm beginning to doubt the reportings of this company

You're a little slow but you're starting to understand.......there will be no audit, and it is likely that the "reportings" are all fictitious.
BMXI
QueenVic QueenVic 5 minutes ago
...Bless your heart- waiting and holding for 17 years!

Now this upcoming NEW YEAR will be a calling for all of us to see the Messiah #47 (I'm saying this since there's some twits on the hubber that frown upon anything of good human nature)

Get your gear ready for that "
crazy horse 0 crazy horse 0 6 minutes ago
I hope that coward gets what he deserves

Watch: Screaming Fight Between GOP Rep, Secret Service Director at Trump Assassination Attempt Hearing

https://truthpress.com/news/watch-screaming-fight-between-gop-rep-secret-service-director-at-trump-assassination-attempt-heari
THEBEASTMUGABI THEBEASTMUGABI 6 minutes ago
Had to google Double top Breakout JJ.  I'm learning slowly, only by definitions though.  I can't read charts so I rely on you all.   It said double top breakout was a bearish sign and you put a bullish sign up.  Not doubting you, I'm just trying to understand.  Keep it up, I appreciate all the comme
IONQ
boominator boominator 6 minutes ago
LANL researchers complete HALEU criticality experiment
Friday, 29 November 2024

The Deimos experiment at Los Alamos National Laboratory is the first criticality experiment using high assay low-enriched uranium fuel to be carried out in the USA in more than 20 years, and will he
LTBR
Clark6290 Clark6290 6 minutes ago
Are you still sleeping Amigo
FNMA
3331 3331 7 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT ACTIPATCH ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of medicin
varmit varmit 7 minutes ago
I nrver did get my tiger hemp beer dividends 
NSAV
MrSmith101 MrSmith101 7 minutes ago
I’m not sure declaes understands what DD means lol. Declaes thinks Due Diligence is just blurting out a random number. There’s no basis for 25 million in revenue even without considering operating costs. Plus paying Edgewater’s medicaid fraud settlement that’s in the millions.
GRST
Snake River Dog Snake River Dog 8 minutes ago
Possible Mention In Wall Street!! This .0001 Stock!! added to this one today. (BYOC.0001) Looking for a nice possible Bounce!! at some Point!! Please read latest News!! 11/12/24

Beyond Commerce Looks to Move Forward with Growth Opportunities After Reaching Confidential Settlements in
BYOC
ChannelTrader ChannelTrader 9 minutes ago
Trump Picks Popular Fox News Contributor for Key Post

https://truthpress.com/news/trump-picks-popular-fox-news-contributor-for-key-post/?utm_source=truthpress.beehiiv.com&utm_medium=newsletter&utm_campaign=unitedhealthcare-ceo-shooter-unmasked&_bhlid=3ad48e204373f53ad7f000726425e8dc72
PantyPuller PantyPuller 10 minutes ago
I mean it was funny a couple times, but now it's just annoying..
VDRM
4retire 4retire 11 minutes ago
Thanks Dallas
NVDA
rickstereo3333 rickstereo3333 11 minutes ago
If there's, to date, nothing major to report, ie an IDE submission date, what would be the point of Pr'ing irrelevant info from the supposedly now concluded Sprint meetings?

If Mk does that the detractors on here will simply "pivot" to the new narrative which will be lambasting the co
RDGL
Real McCoy Real McCoy 11 minutes ago
Well you know it’s not reading comprehension as I’ve bested you here, and you’re out 100%.

What else you wanna talk about?
nwtf nwtf 12 minutes ago
All of this happening and not one leak??? If this were true this issue wouldnt be subzero. Nice delusion youve got going.
ERHE

Your Recent History

Delayed Upgrade Clock